FOXP3 and type 1 diabetes mellitus: In an attempt to characterise the mechanisms of T1D protection elicited by this dosing regimen, we identified a peripheral expansion of FoxP3+ Treg cells that may modulate autoimmune inflammation in a CD73-dependent manner.